NO20011096L - Preventiver eller hjelpemidler for multippel organsvikt - Google Patents

Preventiver eller hjelpemidler for multippel organsvikt

Info

Publication number
NO20011096L
NO20011096L NO20011096A NO20011096A NO20011096L NO 20011096 L NO20011096 L NO 20011096L NO 20011096 A NO20011096 A NO 20011096A NO 20011096 A NO20011096 A NO 20011096A NO 20011096 L NO20011096 L NO 20011096L
Authority
NO
Norway
Prior art keywords
preventives
remedies
organ failure
multiple organ
failure
Prior art date
Application number
NO20011096A
Other languages
English (en)
Norwegian (no)
Other versions
NO20011096D0 (no
Inventor
Tsuyoshi Hara
Kazuko Fujiwara
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO20011096D0 publication Critical patent/NO20011096D0/no
Publication of NO20011096L publication Critical patent/NO20011096L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO20011096A 1998-09-03 2001-03-02 Preventiver eller hjelpemidler for multippel organsvikt NO20011096L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10249492A JP2000080046A (ja) 1998-09-03 1998-09-03 多臓器障害の予防・治療剤
PCT/JP1999/004783 WO2000013707A1 (fr) 1998-09-03 1999-09-03 Medicaments preventifs/et remedes contre la defaillance de plusieurs organes

Publications (2)

Publication Number Publication Date
NO20011096D0 NO20011096D0 (no) 2001-03-02
NO20011096L true NO20011096L (no) 2001-03-02

Family

ID=17193786

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011096A NO20011096L (no) 1998-09-03 2001-03-02 Preventiver eller hjelpemidler for multippel organsvikt

Country Status (12)

Country Link
US (1) US6596754B1 (ja)
EP (1) EP1110556A4 (ja)
JP (1) JP2000080046A (ja)
KR (1) KR20010099628A (ja)
CN (1) CN1315873A (ja)
AU (1) AU5448699A (ja)
CA (1) CA2342796A1 (ja)
ID (1) ID28693A (ja)
IL (1) IL141402A0 (ja)
NO (1) NO20011096L (ja)
TW (1) TW533074B (ja)
WO (1) WO2000013707A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002074313A1 (en) 2001-03-21 2002-09-26 Eisai Co., Ltd. Drugs containing reduced vitamin b¿2?
AU2003284596A1 (en) * 2002-11-22 2004-06-18 Takeda Pharmaceutical Company Limited Imidazole derivative, process for producing the same, and use
CN100513398C (zh) 2002-12-03 2009-07-15 Axys药物公司 作为因子viia抑制剂的2-(2-羟基联苯-3-基)-1h-苯并咪唑-5-甲脒衍生物
TWI396686B (zh) * 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
EP1909795B1 (en) * 2005-06-09 2011-04-13 Bristol-Myers Squibb Company Pharmaceutical composition for use in treating individuals exhibiting mutant kit protein
US10646313B2 (en) 2016-10-12 2020-05-12 Solmetex, L.L.C. Dental amalgam separation and recycling system
EP3610028A1 (en) 2017-04-14 2020-02-19 Capsugel Belgium NV Process for making pullulan
BR112019021391A2 (pt) 2017-04-14 2020-05-05 Capsugel Belgium Nv cápsulas de pululano
US11679093B2 (en) 2018-06-11 2023-06-20 The Regents Of The University Of Colorado, A Body Corporate 2-naphthimidamides, analogues thereof, and methods of treatment using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466668A (en) * 1989-04-28 1995-11-14 Schering Aktiengesellschaft Superior thrombomodulin analogs for pharmaceutical use
US5252725A (en) * 1989-06-23 1993-10-12 The Trustees Of The University Of Pennsylvania α-1-antichymotrypsin, analogues and methods of production
IL101062A0 (en) * 1991-02-28 1992-11-15 Erba Carlo Spa Anti-thrombin polypeptides and their preparation
ZA928276B (en) * 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
JP3388803B2 (ja) * 1993-05-20 2003-03-24 第一製薬株式会社 光学活性７−アミジノナフタレン誘導体の製造法

Also Published As

Publication number Publication date
KR20010099628A (ko) 2001-11-09
NO20011096D0 (no) 2001-03-02
EP1110556A1 (en) 2001-06-27
AU5448699A (en) 2000-03-27
JP2000080046A (ja) 2000-03-21
ID28693A (id) 2001-06-28
CA2342796A1 (en) 2000-03-16
CN1315873A (zh) 2001-10-03
WO2000013707A1 (fr) 2000-03-16
IL141402A0 (en) 2002-03-10
US6596754B1 (en) 2003-07-22
EP1110556A4 (en) 2004-01-28
TW533074B (en) 2003-05-21

Similar Documents

Publication Publication Date Title
DE69927049D1 (de) Risikowachsystem für chirurgische aderpresssysteme
DE69841198D1 (de) Klebstoffzusammensetzung für chirurgische Zwecke
DE69940893D1 (de) Sammelanordnung für medikamente
ITMI991423A0 (it) Fotoiniziatori costituiti da o-acilossime
DE69936170D1 (de) Beatmungsgerät
DE69714904D1 (de) Entlüftungsanordnung für Gebäude
FI980177A0 (fi) Hydrofobiseringssystem foer papper eller en motsvarande fiberprodukt
BR9706908A (pt) Composiçães para o tratamento de insuficiéncia renal compreendendo l-carnosina
NO20011096D0 (no) Preventiver eller hjelpemidler for multippel organsvikt
ATE254214T1 (de) Mehrschichtiges seidenpapier
ID23318A (id) Rakitan lanset bersegmen
EP1297839A4 (en) THERAPEUTIC AND PROPHYLACTIC AGENTS FOR CARDIAC INSUFFICIENCY
EA200000641A1 (ru) Многослойная коммутационная плата
KR980000079U (ko) 축사의 비상시 환기장치
DE9401979U1 (de) Heizkörper für Wohnräume o.dgl.
FI980867A (fi) Laakerielin
DE29619321U1 (de) Magazinierstreifen für Schrauben o.dgl.
NO993145D0 (no) Sjokolade eller sammensatt overtrekk
DE29805265U1 (de) Papierbefeuchter
FI980098A0 (fi) Anordning i torkpartiet i en bestrykningsanordning, pappersmaskin eller motsvarande
DK1091875T3 (da) Pillesikkert eller pillemodstandsdygtigt lukke
NO20004825D0 (no) Driftsystem for luftfartøy
FI980589A0 (fi) Hoernkamin foer anvaendning i en semesterstuga eller liknande
DE29515153U1 (de) Feuchtigkeitssperre für Laminatböden o.dgl.
DE29806668U1 (de) Propeller

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application